Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Fiber shaft extension in combination with HI loop ligands augments infectivity for CAR-negative tumor targets but does not enhance hepatotropism in vivo

Abstract

Recent studies demonstrate that the fiber shaft length, which ranges from six β-repeats to 23 β-repeats in human adenoviruses (Ads), influences viral tropism. We have previously shown that artificial extension of the shaft length inhibits infectivity in CAR (coxsackievirus and Ad receptor)-positive cell lines, but does not affect infectivity in a CAR-independent, integrin-dependent cell entry pathway. On the basis of these findings, we hypothesized that Ad vectors with shaft extension might display lower infectivity in liver, which expresses high levels of CAR. We also postulated that infectivity of Ad vectors with shaft extension in CAR-negative tumors could be increased by exploiting a CAR-independent cell entry by incorporation of an RGD4C motif into the fiber knob HI-loop. We thus compared gene transfer efficiencies of our Ad serotype 5 (Ad5) capsid-based ‘longer-shafted’ Ad vector with or without an RGD4C motif in the HI-loop of the fiber knob (Ad5long and Ad5RGDlong, 32 β-repeats) to wild-type Ad vector (Ad5, 22 β-repeats) in vitro and in vivo. In this study, Ad5long showed similar infectivity in CAR-negative tumors (69.7%, P = 0.098), but significantly reduced infectivity in CAR-positive tumors (19.1%, P = 0.000038) and in liver (12.5%, P = 0.0047) compared with Ad5. On the other hand, Ad5RGDlong demonstrated similar infectivity in CAR-positive tumors (70.5%, P = 0.012) and in liver (83.4%, P = 0.51), but significantly increased infectivity in CAR-negative tumors (327%, P = 0.0000042) compared with Ad5. Importantly, Ad5RGDlong demonstrated an augmented gene transfer capacity for CAR negative tumors, but no enhanced hepatotropism in vivo. We suggest that Ad vectors with artificial fiber shaft extension in combination with HI loop ligands may be useful for gene therapy applications.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Russell WC . Update on adenovirus and its vectors J Gen Virol 2000 81: 2573–2604

    Article  CAS  PubMed  Google Scholar 

  2. Zabner J et al. Lack of high affinity fiber receptor activity explains the resistance of ciliated airway epithelia to adenovirus infection J Clin Invest 1997 100: 1144–1149

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Pickles RJ et al. Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer J Virol 1998 72: 6014–6023

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Douglas JT et al. Targeted gene delivery by tropism-modified adenoviral vectors Nat Biotechnol 1996 14: 1574–1578

    Article  CAS  PubMed  Google Scholar 

  5. Goldman CK et al. Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor Cancer Res 1997 57: 1447–1451

    CAS  PubMed  Google Scholar 

  6. Krasnykh V et al. Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob J Virol 1998 72: 1844–1852

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Wickham TJ, Roelvink PW, Brough DE, Kovesdi I . Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types Nat Biotechnol 1996 14: 1570–1573

    Article  CAS  PubMed  Google Scholar 

  8. Crompton J, Toogood CI, Wallis N, Hay RT . Expression of a foreign epitope on the surface of the adenovirus hexon J Gen Virol 1994 75: 133–139

    Article  CAS  PubMed  Google Scholar 

  9. Wickham TJ, Carrion ME, Kovesdi I . Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs Gene Therapy 1995 2: 750–756

    CAS  PubMed  Google Scholar 

  10. Gall J, Kass-Eisler A, Leinwand L, Falck-Pedersen E . Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes J Virol 1996 70: 2116–2123

    CAS  PubMed  PubMed Central  Google Scholar 

  11. van der Eb MM . Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration Gene Therapy 1998 5: 451–458

    Article  CAS  PubMed  Google Scholar 

  12. Bilbao R et al. Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir therapy of hepatocellular carcinoma: the woodchuck animal model Cancer Gene Ther 2000 7: 657–662

    Article  CAS  PubMed  Google Scholar 

  13. Huard J et al. The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants Gene Therapy 1995 2: 107–115

    CAS  PubMed  Google Scholar 

  14. Worgall S, Wolff G, Falck-Pedersen E, Crystal RG . Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration Hum Gene Ther 1997 8: 37–34

    Article  CAS  PubMed  Google Scholar 

  15. Reynolds PN, Dmitriev I, Curiel DT . Insertion of an RGD motif into the HI loop of adenovirus fiber protein alters the distribution of transgene expression of the systemically administered vector Gene Therapy 1999 6: 1336–1339

    Article  CAS  PubMed  Google Scholar 

  16. Alemany R, Suzuki K, Curiel DT . Blood clearance rates of adenovirus type 5 in mice J Gen Virol 2000 81: 2605–2609

    Article  CAS  PubMed  Google Scholar 

  17. Dmitriev I et al. Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells J Virol 2000 74: 6875–6884

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Seki T et al. Artificial extension of the adenovirus fiber shaft inhibits infectivity in coxsackievirus and adenovirus receptor-positive cell lines J Virol 2002 76: 1100–1108

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Dmitriev I et al. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism J Virol 1998 72: 9706–9713

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Fechner H et al. Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers Gene Therapy 1999 6: 1520–1535

    Article  CAS  PubMed  Google Scholar 

  21. Yee D et al. Adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase in an ascites model of human breast cancer Hum Gene Ther 1996 7: 1251–1257

    Article  CAS  PubMed  Google Scholar 

  22. Einfeld DA et al. Construction of a pseudoreceptor that mediates transduction by adenoviruses expressing a ligand in fiber or penton base J Virol 1999 73: 9130–9136

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Roelvink PW et al. Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae Science 1999 286: 1568–1571

    Article  CAS  PubMed  Google Scholar 

  24. Alemany R, Curiel DT . CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors Gene Therapy 2001 8: 1347–1353

    Article  CAS  PubMed  Google Scholar 

  25. Reynolds PN et al. Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo Nat Biotechnol 2001 19: 838–842

    Article  CAS  PubMed  Google Scholar 

  26. van Raaij MJ, Mitraki A, Lavigne G, Cusack S . A triple beta-spiral in the adenovirus fibre shaft reveals a new structural motif for a fibrous protein Nature 1999 401: 935–938

    Article  CAS  PubMed  Google Scholar 

  27. Krasnykh V, Mikheeva GV, Douglas JT, Curiel DT . Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism J Virol 1996 70: 6839–6846

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Maizel JVJ, White DO, Scharff MD . The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12 Virology 1968 36: 115–125

    Article  CAS  PubMed  Google Scholar 

  29. Karayan L, Gay B, Gerfaux J, Boulanger PA . Oligomerization of recombinant penton base of adenovirus type 2 and its assembly with fiber in baculovirus-infected cells Virology 1994 202: 782–795

    Article  CAS  PubMed  Google Scholar 

  30. Kashentseva EA, Seki T, Curiel DT, Dmitriev IP . Adenovirus targeting to c-erbB-2 oncoprotein by single-chain antibody fused to trimeric form of adenovirus receptor ectodomein Cancer Res 2002 62: 609–616

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Victor Krasnykh for providing plasmids pNEB.PK.FSP and pVK50 and David Dion and Alexander Landar for expert assistance in obtaining reagents. We also thank Joel N Glasgow and Joanne T Douglas for reviewing the manuscript and CFAR DNA Sequencing Core in the University of Alabama at Birmingham for sequencing. This study was supported by National Institutes of Health grants R01 CA74242 and contract No. 1 CO 97110.

Author information

Authors and Affiliations

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seki, T., Dmitriev, I., Suzuki, K. et al. Fiber shaft extension in combination with HI loop ligands augments infectivity for CAR-negative tumor targets but does not enhance hepatotropism in vivo. Gene Ther 9, 1101–1108 (2002). https://doi.org/10.1038/sj.gt.3301815

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/sj.gt.3301815

Keywords

This article is cited by

Search

Quick links